QL2108

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QL2108, covering 2025-03-12 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅲ Comparative Study of QL2108 to Dupixent® [Phase 3]